February 2005 PDF Print E-mail
D'Addario G, Pintilie M, Leighl NB, Feld R, Cerny T, Shepherd FA.  
Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a meta-analysis of the published literature.
J Clin Oncol. 2005 May 1;23(13):2926-36. Epub 2005 Feb 22.
Soares HP, Kumar A, Daniels S, Swann S, Cantor A, Hozo I, Clark M, Serdarevic F, Gwede C, Trotti A, Djulbegovic B.  
Evaluation of new treatments in radiation oncology: are they better than standard treatments?
JAMA. 2005 Feb 23;293(8):970-8.
Kramer NM, Horwitz EM, Cheng J, Ridge JA, Feigenberg SJ, Cohen RB, Nicolaou N, Sherman EJ, Babb JS, Damsker JA, Langer CJ.  
Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies.
Head Neck. 2005 May;27(5):406-14.
Jones WG, Fossa SD, Mead GM, Roberts JT, Sokal M, Horwich A, Stenning SP.  
Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I Testicular Seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328).
J Clin Oncol. 2005 Feb 20;23(6):1200-8.
Sathya JR, Davis IR, Julian JA, Guo Q, Daya D, Dayes IS, Lukka HR, Levine M.  
Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate.
J Clin Oncol. 2005 Feb 20;23(6):1192-9.
Budach V, Stuschke M, Budach W, Baumann M, Geismar D, Grabenbauer G, Lammert I, Jahnke K, Stueben G, Herrmann T, Bamberg M, Wust P, Hinkelbein W, Wernecke KD.  
Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial.
J Clin Oncol. 2005 Feb 20;23(6):1125-35.
Astreinidou E, Bel A, Raaijmakers CP, Terhaard CH, Lagendijk JJ.  
Adequate margins for random setup uncertainties in head-and-neck IMRT.
Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):938-44.
Yu J, Li G, Li J, Wang Y.  
The pattern of lymphatic metastasis of breast cancer and its influence on the delineation of radiation fields.
Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):874-8.
Chow E, Davis L, Panzarella T, Hayter C, Szumacher E, Loblaw A, Wong R, Danjoux C.  
Accuracy of survival prediction by palliative radiation oncologists.
Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):870-3.
Monroe AT, Bhandare N, Morris CG, Mendenhall WM.  
Preventing radiation retinopathy with hyperfractionation.
Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):856-64.
Nieder C, Grosu AL, Andratschke NH, Molls M.  
Proposal of human spinal cord reirradiation dose based on collection of data from 40 patients.
Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):851-5. Review.
Milker-Zabel S, Zabel A, Schulz-Ertner D, Schlegel W, Wannenmacher M, Debus J.  
Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: long-term experience and prognostic factors.
Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):809-16.
Paek SH, Downes MB, Bednarz G, Keane WM, Werner-Wasik M, Curran WJ Jr, Andrews DW.  
Integration of surgery with fractionated stereotactic radiotherapy for treatment of nonfunctioning pituitary macroadenomas.
Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):795-808. Review.
Hansen O, Larsen S, Bastholt L, Godballe C, Jorgensen KE.  
Duration of symptoms: impact on outcome of radiotherapy in glottic cancer patients.
Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):789-94.
Hong TS, Tome WA, Chappell RJ, Chinnaiyan P, Mehta MP, Harari PM.  
The impact of daily setup variations on head-and-neck intensity-modulated radiation therapy.
Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):779-88.
Sanguineti G, Richetti A, Bignardi M, Corvo' R, Gabriele P, Sormani MP, Antognoni P.  
Accelerated versus conventional fractionated postoperative radiotherapy for advanced head and neck cancer: results of a multicenter Phase III study.
Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):762-71.
Niazi TM, Souhami L, Sultanem K, Duclos M, Shenouda G, Freeman C.  
Long-term results of para-aortic irradiation for patients with stage I seminoma of the testis.
Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):741-4.
Choo R, Thomas G, Woo T, Lee D, Kong B, Iscoe N, Danjoux C, Klotz L, Morton G, Chander S.  
Long-term outcome of postorchiectomy surveillance for Stage I testicular seminoma.
Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):736-40.
Vargas C, Kestin LL, Weed DW, Krauss D, Vicini FA, Martinez AA.  
Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):714-24.
Jacob R, Hanlon AL, Horwitz EM, Movsas B, Uzzo RG, Pollack A.  
Role of prostate dose escalation in patients with greater than 15% risk of pelvic lymph node involvement.
Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):695-701.
Chan AK, Wong A, Jenken D, Heine J, Buie D, Johnson D.  
Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.
Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):665-77.
Nicolato A, Giorgetti P, Foroni R, Grigolato D, Pasquin IP, Zuffante M, Soda C, Tomassini A, Gerosa M.  
Gamma knife radiosurgery in skull base meningiomas: a possible relationship between somatostatin receptor decrease and early neurological improvement without tumour shrinkage at short-term imaging follow-up.
Acta Neurochir (Wien). 2005 Apr;147(4):367-75.
Chang SM, Parney IF, Huang W, Anderson FA Jr, Asher AL, Bernstein M, Lillehei KO, Brem H, Berger MS, Laws ER; Glioma Outcomes Project Investigators.  
Patterns of care for adults with newly diagnosed malignant glioma.
JAMA. 2005 Feb 2;293(5):557-64.
Shioyama Y, Nakamura K, Sasaki T, Ooga S, Urashima Y, Kimura M, Uehara S, Terashima H, Honda H.  
Clinical results of radiation therapy for stage I esophageal cancer: a single institutional experience.
Am J Clin Oncol. 2005 Feb;28(1):75-80.
Katz TS, Amdur RJ, Yachnis AT, Mendenhall WM, Morris CG.  
Pushing the limits of radiotherapy for atypical and malignant meningioma.
Am J Clin Oncol. 2005 Feb;28(1):70-4.
Taylor JM, Yu M, Sandler HM.  
Individualized predictions of disease progression following radiation therapy for prostate cancer.
J Clin Oncol. 2005 Feb 1;23(4):816-25.
Lawton CA, Winter K, Grignon D, Pilepich MV.  
Androgen suppression plus radiation versus radiation alone for patients with stage D1/pathologic node-positive adenocarcinoma of the prostate: updated results based on national prospective randomized trial Radiation Therapy Oncology Group 85-31.
J Clin Oncol. 2005 Feb 1;23(4):800-7.
Brouha XD, Tromp DM, de Leeuw JR, Hordijk GJ, Winnubst JA.  
Laryngeal cancer patients: analysis of patient delay at different tumor stages.
Head Neck. 2005 Apr;27(4):289-95.
Wong JR, Grimm L, Uematsu M, Oren R, Cheng CW, Merrick S, Schiff P.  
Image-guided radiotherapy for prostate cancer by CT-linear accelerator combination: prostate movements and dosimetric considerations.
Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):561-9.
Stalpers LJ, da Costa HC, Merbis MA, Fortuin AA, Muller MJ, van Dam FS.  
Hypnotherapy in radiotherapy patients: a randomized trial.
Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):499-506.
DeLaney TF, Park L, Goldberg SI, Hug EB, Liebsch NJ, Munzenrider JE, Suit HD.  
Radiotherapy for local control of osteosarcoma.
Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):492-8.
Chua DT, Ma J, Sham JS, Mai HQ, Choy DT, Hong MH, Lu TX, Min HQ.  
Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials.
J Clin Oncol. 2005 Feb 20;23(6):1118-24. Epub 2005 Jan 18.
Tomura N, Izumi J, Anbai A, Takahashi S, Sakuma I, Omachi K, Kidani H, Sasaki K, Watarai J, Suzuki A, Mizoi K.  
Thallium-201 SPECT in the evaluation of early effects on brain tumors treated with stereotactic irradiation.
Clin Nucl Med. 2005 Feb;30(2):83-6.
Josting A, Nogova L, Franklin J, Glossmann JP, Eich HT, Sieber M, Schober T, Boettcher HD, Schulz U, Muller RP, Diehl V, Engert A.  
Salvage radiotherapy in patients with relapsed and refractory Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Lymphoma Study Group.
J Clin Oncol. 2005 Mar 1;23(7):1522-9. Epub 2005 Jan 4.
Taussky D, Dulguerov P, Allal AS.  
Salvage surgery after radical accelerated radiotherapy with concomitant boost technique for head and neck carcinomas.
Head Neck. 2005 Mar;27(3):182-6.
Veness MJ, Morgan GJ, Gebski V.  
Adjuvant locoregional radiotherapy as best practice in patients with Merkel cell carcinoma of the head and neck.
Head Neck. 2005 Mar;27(3):208-16.
Leung WM, Tsang NM, Chang FT, Lo CJ.  
Lhermitte's sign among nasopharyngeal cancer patients after radiotherapy.
Head Neck. 2005 Mar;27(3):187-94.
 
[ Back ]